The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SLN SILENCE THERAPEUTICS PLC ORD 5P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
16:05 17-Aug-2017 SLN Replacement - Holding(s) in Company RNS +5.35% Up
07:00 15-Aug-2017 SLN Two further US patents to be granted RNS +6.30% Up
07:00 03-Aug-2017 SLN Director/PDMR Shareholding RNS -1.27% Down
11:43 31-Jul-2017 SLN Director/PDMR Shareholding RNS +5.10% Up
07:00 31-Jul-2017 SLN Holding(s) in Company RNS +5.10% Up
07:00 31-Jul-2017 SLN US patent to be granted RNS +5.10% Up
14:43 27-Jul-2017 SLN Licensee Quark Announces Positive AKI Results RNS +18.70% Up
07:00 24-Jul-2017 SLN Presenting at Canaccord Genuity Growth Conference RNS +17.74% Up
07:00 24-Jul-2017 SLN Silence Strengthens US Patent Estate RNS +17.74% Up
07:00 14-Jul-2017 SLN CEO Ali Mortazavi appointed Chairman of Ultromics RNS +4.09% Up
07:41 10-Jul-2017 SLN IP update RNS +6.84% Up
14:34 03-Jul-2017 SLN Issue of claim in the UK High Courts RNS +1.66% Up
07:00 03-Jul-2017 SLN Change of Adviser RNS +1.66% Up
11:47 29-Jun-2017 SLN Holding(s) in Company RNS -0.16% Down
07:00 06-Jun-2017 SLN Result of AGM RNS -1.40% Down
07:00 01-Jun-2017 SLN Hiring of Chief Operating Officer RNS +0.15% Up
07:00 30-May-2017 SLN Continued Expansion of IP RNS +2.09% Up
07:00 16-May-2017 SLN Significant Expansion of Intellectual Property RNS +14.11% Up
12:05 04-May-2017 SLN Notice of AGM and Publication of Annual Report RNS +0.07% Up
07:00 03-May-2017 SLN Silence Therapeutics Presents New Data RNS -5.15% Down

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Updated Monthly
Company address 1 Lyric Square, London, W6 0NB, United Kingdom
Company website http://www.silence-ther...
Market cap(in millions)* £ 106.74
Listing/Admission to trading 05 Jan 2010
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
22-Aug-17
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 3,000
SEDOL B9GTXM6
ISIN number GB00B9GTXM62



SILENCE THER. share news analysis (SLN)